AI is about to change healthcare. These 38 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own AXIS Capital, you need to believe in its shift toward specialty insurance and in its ability to turn technology spending into better underwriting efficiency. The Q2 earnings miss and 16.1% share price drop sharpen the focus on near term execution risk, but do not fundamentally alter the main catalyst of improving margins in specialty lines or the key risk around expense discipline and loss volatility.
The most relevant recent announcement here is AXIS’s Q2 2026 update itself, where revenue, net income, and EPS all came in below analyst expectations. This result directly tests the thesis that technology, AI driven underwriting, and a more focused portfolio can steadily lift profitability, while also reminding investors that catastrophe losses, competitive pressure, and higher litigation costs can still strain results even as the company invests for efficiency.
But against this, investors should be aware that rising cyber, casualty, and litigation exposures could...
Read the full narrative on AXIS Capital Holdings (it's free!)
AXIS Capital Holdings' narrative projects $7.2 billion revenue and $1.1 billion earnings by 2029.
Uncover how AXIS Capital Holdings' forecasts yield a $126.09 fair value, a 26% upside to its current price.
Members of the Simply Wall St Community have published fair value estimates for AXIS between US$126.09 and US$303.96 across 2 separate views, underscoring how far opinions can diverge. You can set those side by side with the recent earnings miss and ongoing expense ratio risks to form your own view on how the company might perform over time.
Explore 2 other fair value estimates on AXIS Capital Holdings - why the stock might be worth just $126.09!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Every day counts. These free picks are already gaining attention. See them before the crowd does:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com